← Back to Analyst Consensus 
DH Hold
Definitive Healthcare Corp.
Current Price —
Implied Upside —
Analysts 15
30-Day Momentum
▲ 0 upgrades / ▼ 0 downgrades / 0 reiterations from 0 firms
Next Earnings
Nov 5, 2026 (10 days)
Rating Timeline
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Aug 11, 2026 | Morgan Stanley | maintain | Equal-Weight → Equal-Weight | — | 54% |
| Jun 29, 2026 | B of A Securities | downgrade | Buy → Underperform | — | 53% |
| Mar 30, 2026 | Barclays | maintain | Underweight → Underweight | — | 53% |
| Feb 27, 2026 | Canaccord Genuity | maintain | Hold → Hold | $3 | 48% |
| Feb 27, 2026 | Stephens & Co. | maintain | Equal-Weight → Equal-Weight | $2 | 54% |
| Dec 9, 2025 | Barclays | maintain | Underweight → Underweight | $2.75 | 53% |
| Nov 10, 2025 | Canaccord Genuity | maintain | Hold → Hold | $4 | 48% |
| Aug 8, 2025 | Stifel | maintain | Buy → Buy | $6 | 53% |
| May 12, 2025 | Goldman Sachs | maintain | Neutral → Neutral | $3.4 | 54% |
| Mar 4, 2025 | Goldman Sachs | maintain | Neutral → Neutral | $3 | 54% |
| Mar 3, 2025 | Barclays | maintain | Underweight → Underweight | $3 | 53% |
| Jan 16, 2025 | Needham | reiterate | Hold → Hold | $0 | 50% |
| Jan 13, 2025 | Barclays | downgrade | Equal-Weight → Underweight | $4 | 53% |
| Dec 20, 2024 | Stephens & Co. | initiate | — → Equal-Weight | $5 | 54% |
| Nov 8, 2024 | Needham | reiterate | — → Hold | $0 | 50% |
| Sep 17, 2024 | BTIG | initiate | — → Buy | $7 | 52% |
| Aug 9, 2024 | Deutsche Bank | maintain | Hold → Hold | $5 | 57% |
| Aug 7, 2024 | Barclays | maintain | Equal-Weight → Equal-Weight | $4 | 53% |
| Aug 7, 2024 | Baird | maintain | Neutral → Neutral | $5 | 55% |
| Aug 6, 2024 | Morgan Stanley | maintain | Equal-Weight → Equal-Weight | $5 | 54% |
| Aug 6, 2024 | Needham | reiterate | — → Hold | $0 | 50% |
| Jul 31, 2024 | Stifel | maintain | Buy → Buy | $7.5 | 53% |
| Jul 31, 2024 | Barclays | maintain | Equal-Weight → Equal-Weight | $6 | 53% |
| Jul 31, 2024 | Baird | maintain | Neutral → Neutral | $6 | 55% |
| Jul 31, 2024 | JP Morgan | downgrade | Neutral → Underweight | $5 | 54% |
| Jul 31, 2024 | Needham | reiterate | — → Hold | $0 | 50% |
| May 9, 2024 | Deutsche Bank | maintain | Hold → Hold | $7 | 57% |
| May 9, 2024 | Barclays | maintain | Equal-Weight → Equal-Weight | $7 | 53% |
| May 8, 2024 | Canaccord Genuity | maintain | Hold → Hold | $8 | 48% |
| May 8, 2024 | Stifel | maintain | Buy → Buy | $9.5 | 53% |
| May 8, 2024 | Needham | reiterate | — → Hold | $0 | 50% |
| May 8, 2024 | Morgan Stanley | downgrade | Overweight → Equal-Weight | $9 | 54% |
| Mar 1, 2024 | Barclays | maintain | Equal-Weight → Equal-Weight | $11 | 53% |
| Feb 29, 2024 | Canaccord Genuity | maintain | Hold → Hold | $10 | 48% |
| Jan 17, 2024 | Stifel | maintain | Buy → Buy | $11 | 53% |
| Jan 17, 2024 | Needham | downgrade | Buy → Hold | $0 | 50% |
| Jan 5, 2024 | Canaccord Genuity | downgrade | Buy → Hold | $10 | 48% |
| Nov 3, 2023 | Morgan Stanley | maintain | Overweight → Overweight | $9.5 | 54% |
| Aug 16, 2023 | Goldman Sachs | maintain | Neutral → Neutral | $10.5 | 54% |
| Aug 15, 2023 | Canaccord Genuity | maintain | Buy → Buy | $12 | 48% |
| Aug 15, 2023 | Morgan Stanley | maintain | Overweight → Overweight | $15 | 54% |
| Aug 15, 2023 | B of A Securities | maintain | Neutral → Neutral | $10.5 | 53% |
| Aug 15, 2023 | Needham | reiterate | Buy → Buy | $15 | 50% |
| Aug 1, 2023 | Needham | reiterate | Buy → Buy | $15 | 50% |
| Jul 24, 2023 | Baird | downgrade | Outperform → Neutral | $13 | 55% |
| Jun 16, 2023 | Needham | reiterate | — → Buy | $15 | 50% |
| May 8, 2023 | Barclays | maintain | — → Equal-Weight | $10 | 53% |
| May 5, 2023 | B of A Securities | maintain | Neutral → Neutral | $11 | 53% |
| May 5, 2023 | Credit Suisse | maintain | — → Neutral | $12 | — |
| May 5, 2023 | Needham | reiterate | — → Buy | $15 | 50% |
Price Target Trend
Apr 25, 2026 Oct 26, 2026
EPS Estimates
+1q —
+1y —
0y —
0q —
Cross-Platform Signals
No cross-platform signals in the last 90 days